PT/INR
Prothrombin Time measures extrinsic pathway clotting. INR standardizes PT for warfarin monitoring. Target INR 2-3 for most conditions, 2.5-3.5 for mechanical heart valves.
Learn MoreEssential tests for evaluating bleeding disorders, thrombotic risk, and anticoagulation therapy monitoring.
Prothrombin Time measures extrinsic pathway clotting. INR standardizes PT for warfarin monitoring. Target INR 2-3 for most conditions, 2.5-3.5 for mechanical heart valves.
Learn MoreActivated Partial Thromboplastin Time measures intrinsic and common pathway. Monitors heparin therapy (target 1.5-2.5× control). Prolonged in hemophilia A/B and lupus anticoagulant.
Learn MoreEssential clotting protein converted to fibrin clot. Low in DIC, liver disease, massive hemorrhage. Elevated as acute phase reactant in inflammation, pregnancy, malignancy.
Learn MoreFibrin degradation product indicating active clot breakdown. Highly sensitive for VTE (DVT/PE) - negative D-dimer effectively rules out thrombosis. Elevated in many conditions (low specificity).
Learn More